Content with tag biosimilars .

MedImpact Holds 2016 Annual Trend to 2.9 Percent

MedImpact, an independent, trend-focused PBM, held its 2016 overall annual trend to a mere 2.9 percent. The MedImpact Annual Trend Report examined the annual trend by...
Read More About MedImpact Holds 2016 Annual Trend to 2.9 Percent »
6/11/18 health drug information pcsk9s specialty self-funded diabetes market updates pbm prescription drugs biosimilars low-net cost drug inflation blockbuster drugs rising drug costs trend report 127161 Views

5 Reasons You Won’t Want to Miss The MedImpact Annual Conference

  The MedImpact conference is only 5 weeks away! Don’t miss out on the opportunity to hear from industry experts on all the hot topics affecting...
Read More About 5 Reasons You Won’t Want to Miss The MedImpact Annual Conference »
1/31/17 specialty annual conference 340b biosimilars low-net cost 121034 Views